New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For NDAQ;AAPL;BBRY;HD;GOOG;REGN;SNY;NVO;HEK;GMCR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | all recent news | >>
October 20, 2014
11:06 EDTAAPLWalgreen begins accepting Apple Pay in stores
Subscribe for More Information
10:55 EDTAAPLApple technical comments ahead of earnings
Subscribe for More Information
10:37 EDTSNYSanofi unit announces Aubagio gains FDA approval due to study data
Genzyme, a Sanofi company, announced that the Food and Drug Administration has approved the inclusion of efficacy and safety data from the TOWER and TOPIC studies of once-daily, oral Aubagio in the productís U.S. label. In the TOWER study, patients with relapsing MS receiving Aubagio 14 mg had a statistically significant reduction in annualized relapse rate and relative risk of sustained disability progression compared to placebo. In addition, a significant reduction in annualized relapse rate was observed in patients treated with Aubagio 7 mg compared to placebo. The TOPIC study was designed to assess whether initiation of Aubagio in patients who experienced their first neurological symptoms suggestive of MS could prevent or delay a second clinical attack. In this study, the proportion of patients free of relapse was statistically significantly greater for Aubagio 14 mg and 7 mg, compared to placebo. Results of the TOPIC study were published in The Lancet Neurology in September.
09:36 EDTAAPL, GOOGActive equity options trading on open
Subscribe for More Information
09:31 EDTGOOGRobinhood.org to hold conference
Subscribe for More Information
09:27 EDTAAPLDexCom announces Dexcom SHARE FDA approval
Dexcom (DXCM) announced that it has received U.S. Food and Drug Administration approval for its CGM remote mobile communications device, Dexcom SHARE. With Dexcom SHARE, parents and personal caregivers can monitor a person's glucose data from a remote location via an Apple (AAPL) iPhone, or iPod touch.
09:01 EDTAAPLOffice Depot stores now accept Apple Pay
Subscribe for More Information
08:44 EDTAAPLIBM CEO says recent Apple, SAP deals represent change in partnering strategy
Subscribe for More Information
08:32 EDTAAPLFirst Tennessee to offer Apple Pay
Subscribe for More Information
08:06 EDTSNYMerck, Sanofi unit announce pediatric hexavalent vaccine BLA
Subscribe for More Information
08:00 EDTAAPLApple Pay now available to Whole Foods Market customers
Subscribe for More Information
07:19 EDTSNYIBC Life Sciences to hold a conference
Subscribe for More Information
07:16 EDTREGNAmerican Academy of Ophthalmology to hold annual meeting
AAO Annual Meeting 2014 is being held in Chicago on October 18-21.
07:10 EDTREGN, SNYAmerican Society of Human Genetics to hold annual meeting
Subscribe for More Information
07:02 EDTREGN, SNYRegeneron Sanofi begins dosing in Phase 3 study of dupilumab
Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) announced that the first patients have been dosed in a Phase 3 clinical study of dupilumab, an investigational therapy that blocks IL-4 and IL-13 signaling, in adults with moderate-to-severe atopic dermatitis, or AD, that is not adequately controlled with topical AD medications. LIBERTY AD CHRONOS, the first trial in the Phase 3 clinical program for dupilumab, is a randomized, double-blind, placebo-controlled, multi-national study with the primary objective of demonstrating the efficacy of dupilumab in adults with moderate to severe AD when administered concomitantly with topical corticosteroids through 16 weeks.
06:37 EDTAAPLApple not planning to make touchscreen desktop computers, CNet reports
Subscribe for More Information
06:22 EDTGOOGYouTube's Robert Kyncl considering leaving company, NY Post reports
Subscribe for More Information
06:04 EDTBBRYAcacia Research subsidiary enters into agreement with BlackBerry
Acacia Research announced that its Cell and Network Selection subsidiary entered into an agreement with Blackberry Corporation and Blackberry Limited (BBRY). The agreement resolved litigation that was pending between Cell and Network Selection and Blackberry in the U.S. District Court for the Eastern District of Texas.
06:03 EDTBBRYBlackBerry implied volatility of 51 at lower end of index mean range
Subscribe for More Information
06:01 EDTGOOGGoogle's Hiroshi Lockheimer overseeing Android, Chrome engineering, WSJ says
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use